Immunome (IMNM) R&D/CAPEX US GAAP (year values)

2019 2020 2021 2022 2023   LTM ? CAGR 5 years ?
R&D/CAPEX, % 3 787% 1 277% 17 861% 9 384% 12 414%   5 228%  
Changes by years, y/y, % +770pp -2 509pp +16 583pp -8 477pp +3 030pp     +32.7%

Immunome. R&D/CAPEX, %

Immunome. R&D/CAPEX, changes, pp

Immunome (IMNM) R&D/CAPEX US GAAP (quarter values)

2023Q2 2023Q3 2023Q4 2024Q1 2024Q2   LTM ?
R&D/CAPEX, % 1 681% 10 619% 25 840% 5 872% 1 481%   5 228%
Changes by years, y/y, % -1 682pp +19 935pp +2 180pp -200pp    
Changes by quarters, q/q, % -2 010pp +8 938pp +15 221pp -19 969pp -4 390pp    

Immunome. R&D/CAPEX, %

Immunome. R&D/CAPEX, changes, pp

Immunome. R&D/CAPEX, changes, pp